| scholarly article | Q13442814 |
| P50 | author | Francesco Marincola | Q107723823 |
| Adriana Albini | Q37829005 | ||
| P2093 | author name string | David F Stroncek | |
| Ena Wang | |||
| P2860 | cites work | Structure and Functional Expression of a Human Interleukin-8 Receptor | Q24319897 |
| Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences | Q24336098 | ||
| The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers | Q24535763 | ||
| Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma | Q24548019 | ||
| Polymorphism in clinical immunology - From HLA typing to immunogenetic profiling | Q24798836 | ||
| Translational Medicine: A two-way road | Q24802385 | ||
| Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration | Q24802736 | ||
| Lost in Translation: Obstacles to Translational Medicine | Q24807071 | ||
| Key role of local regulation in chemosensing revealed by a new molecular interaction-based modeling method | Q27339751 | ||
| DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection | Q27469850 | ||
| Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome | Q27471683 | ||
| Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling | Q27860529 | ||
| Introductory science and mathematics education for 21st-Century biologists. | Q51009067 | ||
| The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines. | Q52083402 | ||
| Self-organization, complexity and chaos: the new biology for medicine. | Q52237930 | ||
| Characterization of a C3-like cDNA in a coral: phylogenetic implications. | Q53617919 | ||
| Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. | Q53924174 | ||
| Effects of transforming growth factor beta 1 on rainbow trout Oncorhynchus mykiss macrophage respiratory burst activity. | Q54723604 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| The Human Genome Diversity Project: past, present and future | Q56474224 | ||
| Immunomodulation by recombinant human interleukin-8 and its signal transduction pathways in invertebrate hemocytes | Q57649731 | ||
| Immunology: The ins and outs of antigen processing and presentations | Q59073630 | ||
| Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report | Q68100559 | ||
| A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes | Q68804520 | ||
| Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2 | Q72052802 | ||
| Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo | Q74185524 | ||
| Short-term kinetics of tumor antigen expression in response to vaccination | Q74244357 | ||
| [Immunology in clinical practice. XI. IgG receptors: the role of polymorphism in autoimmune and infectious diseases] | Q74486736 | ||
| The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis | Q77577103 | ||
| Chaos in cancer? | Q77658630 | ||
| Complex disease and the new clinical sciences | Q78009417 | ||
| Obstacles and opportunities in translational research | Q80368689 | ||
| Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imaging | Q80702844 | ||
| Spontaneous and treatment-induced cancer rejection in humans | Q80757169 | ||
| Future of immunotherapy: a call for comparative immunology | Q84573886 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 | ||
| Genetic instabilities in human cancers | Q28131826 | ||
| Of mice and not men: differences between mouse and human immunology | Q28246229 | ||
| Cloning of complementary DNA encoding a functional human interleukin-8 receptor | Q28297523 | ||
| The chemokine system in diverse forms of macrophage activation and polarization | Q29547719 | ||
| Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease | Q29619085 | ||
| Molecular classification of cutaneous malignant melanoma by gene expression profiling | Q29619204 | ||
| The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies | Q29619723 | ||
| Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer | Q29620068 | ||
| Virus evolution: how far does the double beta-barrel viral lineage extend? | Q30157462 | ||
| A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers". | Q30440347 | ||
| 5. Genetics of allergic disease | Q30445523 | ||
| Characterizing emergent properties of immunological systems with multi-cellular rule-based computational modeling | Q30447232 | ||
| Isolation and characterization of lymphocyte-like cells from a lamprey | Q30865033 | ||
| Data for Genetic Analysis Workshop (GAW) 15 Problem 2, genetic causes of rheumatoid arthritis and associated traits | Q31154891 | ||
| Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassays | Q33203235 | ||
| BioNetBuilder: automatic integration of biological networks | Q33265164 | ||
| Tumour biology, chaos and non-linear dynamics | Q33585502 | ||
| Molecular and biological properties of vascular endothelial growth factor | Q33737216 | ||
| Cytokines, chaos, and complexity. | Q33790709 | ||
| A prescription for human immunology | Q34001827 | ||
| A natural history of melanoma: serial gene expression analysis | Q34103318 | ||
| The immune tolerance network: a new paradigm for developing tolerance-inducing therapies | Q34137999 | ||
| The multistep nature of cancer | Q34366937 | ||
| Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance | Q34389314 | ||
| The Human Genome Diversity Project: past, present and future | Q34407929 | ||
| Human evolution and its relevance for genetic epidemiology | Q34615671 | ||
| Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus | Q34702365 | ||
| Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases | Q34704835 | ||
| The immunogenetics of multiple sclerosis | Q34776567 | ||
| Chemokines as natural HIV antagonists | Q35014638 | ||
| Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia. | Q35132088 | ||
| Tumors as elusive targets of T-cell-based active immunotherapy | Q35155955 | ||
| A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease | Q35604700 | ||
| Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection | Q35724734 | ||
| Pleiotropic function of Toll-like receptors | Q35982288 | ||
| Can chromosomal instability initiate tumorigenesis? | Q35990966 | ||
| Bottom up: a modular view of immunology | Q36158286 | ||
| Gene profiling of immune responses against tumors | Q36159966 | ||
| Genetic diversity and new therapeutic concepts | Q36205840 | ||
| Advances in immunology: from bench to bedside--a symposium at the 2005 Annual Meeting of the Federation of Clinical Immunology Societies (FOCIS), Boston, MA, USA. | Q36409418 | ||
| A plaidoyer for 'systems immunology'. | Q36453383 | ||
| Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. | Q36456711 | ||
| Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy | Q36470726 | ||
| Current bioinformatics tools in genomic biomedical research (Review). | Q36473783 | ||
| Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer | Q36481104 | ||
| Autologous tumor rejection in humans: trimming the myths | Q36569014 | ||
| Systemic lupus erythematosus: all roads lead to type I interferons | Q36608558 | ||
| Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates | Q36638580 | ||
| What's next in translational medicine? | Q36708341 | ||
| Dream of scientific brotherhood. | Q36825782 | ||
| Therapeutics targeting tumor immune escape: towards the development of new generation anticancer vaccines | Q36908596 | ||
| Linkage disequilibrium maps and disease-association mapping | Q36994003 | ||
| Microarray-based identification of novel biomarkers in IL-1-mediated diseases | Q37013467 | ||
| Humanized mice for the study of type 1 diabetes and beta cell function | Q37049736 | ||
| Tumour immunity: effector response to tumour and role of the microenvironment | Q37085136 | ||
| A highly invasive human glioblastoma pre-clinical model for testing therapeutics | Q37103825 | ||
| Interferon- alpha and - beta restrict polyomavirus JC replication in primary human fetal glial cells: implications for progressive multifocal leukoencephalopathy therapy | Q37141540 | ||
| The immunologic constant of rejection | Q37155128 | ||
| Applications of computational algorithm tools to identify functional SNPs | Q37194616 | ||
| Fevers, genes, and innate immunity | Q37252309 | ||
| Strategies used for MUC1 immunotherapy: preclinical studies | Q37259594 | ||
| Strategies used for MUC1 immunotherapy: human clinical studies | Q37259597 | ||
| A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus | Q37308037 | ||
| Viral sequence diversity: challenges for AIDS vaccine designs | Q37316023 | ||
| Use of humanized severe combined immunodeficient mice for human vaccine development | Q37354186 | ||
| Analysis of the expression and function of class-II major histocompatibility complex-encoded molecules by DNA-mediated gene transfer | Q39733291 | ||
| Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis. | Q40028715 | ||
| Clonal persistence and evolution during a decade of recurrent melanoma | Q40318233 | ||
| A "minimal essential Mhc" and an "unrecognized Mhc": two extremes in selection for polymorphism | Q40413376 | ||
| MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation | Q40807437 | ||
| A virtual look at Epstein-Barr virus infection: simulation mechanism | Q41976838 | ||
| In support of descriptive studies; relevance to translational research | Q42786231 | ||
| Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity | Q42972501 | ||
| Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race | Q43001565 | ||
| AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies. | Q43059808 | ||
| A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses | Q43939988 | ||
| In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2. | Q44233004 | ||
| Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy | Q44319954 | ||
| Ontogeny and oncogenesis balance the transcriptional profile of renal cell cancer | Q45113168 | ||
| Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study. | Q45263768 | ||
| Evolutionary analysis of human vascular endothelial growth factor, angiopoietin, and tyrosine endothelial kinase involved in angiogenesis and immunity. | Q46572158 | ||
| Immunological paradoxes: theoretical considerations in the rejection or retention of grafts, tumors, and normal tissue | Q47678295 | ||
| P433 | issue | 3 | |
| P921 | main subject | immunotherapy | Q1427096 |
| P304 | page(s) | 355-366 | |
| P577 | publication date | 2009-05-01 | |
| P1433 | published in | Immunotherapy | Q18713038 |
| P1476 | title | New take on comparative immunology: relevance to immunotherapy | |
| P478 | volume | 1 |
| Q30438965 | Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology |
| Q37773248 | Intravenous immunoglobulin-based immunotherapy: an arsenal of possibilities for patients and science |
| Q58234468 | Melanoma & biomarkers of immunoresponsiveness |
| Q51867234 | The trouble with translational medicine. |
| Q33702284 | Translational medicine--doing it backwards |
| Q54956643 | Turning laboratory findings into therapy: a marathon goal that has to be reached. |
Search more.